Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy LivaNova stock

Learn how to easily invest in LivaNova stock.

LivaNova PLC is a medical devices business based in the US. LivaNova shares (LIVN) are listed on the NASDAQ and all prices are listed in US Dollars. LivaNova employs 4,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in LivaNova

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LIVN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

LivaNova stock price (NASDAQ: LIVN)

Use our graph to track the performance of LIVN stocks over time.

LivaNova shares at a glance

Information last updated 2022-01-10.
Latest market close$84.78
52-week range$61.76 - $93.89
50-day moving average $84.32
200-day moving average $82.53
Wall St. target price$106.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-8.23

Buy LivaNova shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy LivaNova stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LivaNova price performance over time

Historical closes compared with the close of $84.78 from 2022-01-14

1 week (2022-01-05) N/A
1 month (2021-12-16) 9.68%
3 months (2021-10-15) 1.06%
6 months (2021-07-16) 9.11%
1 year (2021-01-15) 24.48%
2 years (2020-01-16) 12.80%
3 years (2019-01-16) 90.11
5 years (2017-01-13) 78.94%

Is LivaNova stock undervalued or overvalued?

Valuing LivaNova stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LivaNova's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LivaNova's PEG ratio

LivaNova's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.0239. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LivaNova's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LivaNova's EBITDA

LivaNova's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $64.3 million.

The EBITDA is a measure of a LivaNova's overall financial performance and is widely used to measure a its profitability.

LivaNova financials

Revenue TTM $1 billion
Operating margin TTM 0.97%
Gross profit TTM $605.3 million
Return on assets TTM 0.27%
Return on equity TTM -30.53%
Profit margin -39.34%
Book value $24.66
Market capitalisation $4.3 billion

TTM: trailing 12 months

LivaNova share dividends

We're not expecting LivaNova to pay a dividend over the next 12 months.

LivaNova share price volatility

Over the last 12 months, LivaNova's shares have ranged in value from as little as $61.76 up to $93.89. A popular way to gauge a stock's volatility is its "beta".

LIVN.US volatility(beta: 0.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LivaNova's is 0.8936. This would suggest that LivaNova's shares are less volatile than average (for this exchange).

LivaNova overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers.

Frequently asked questions

What percentage of LivaNova is owned by insiders or institutions?
Currently 0.403% of LivaNova shares are held by insiders and 106.01% by institutions.
How many people work for LivaNova?
Latest data suggests 4,000 work at LivaNova.
When does the fiscal year end for LivaNova?
LivaNova's fiscal year ends in December.
Where is LivaNova based?
LivaNova's address is: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
What is LivaNova's ISIN number?
LivaNova's international securities identification number is: GB00BYMT0J19
What is LivaNova's CUSIP number?
LivaNova's Committee on Uniform Securities Identification Procedures number is: G5509L101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site